Haematology

Prof. Dr. S. Sami Kartı

Doctor and researcher Acıbadem Atakent Hastanesi İstanbul
Multiple MyelomaLiver FailureLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Multiple Myeloma 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Liver Failure 3 publications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Akut Lenfoblastik Lösemi (ALL)
  • Akut Miyeloid Lösemi (AML)
  • Anemi
  • Demir Eksikliği Anemisi
  • ITP Hastalığı
  • KML (Kronik Miyeloid Lösemi)
  • Von Willebrand Hastalığı
  • Kemik İliği Nakli
  • Kemik İliği Hastalıkları
  • Multipl Miyelom

CV

Education and experience

From source

Experience

  • 2013Acıbadem Sağlık Grubuacibadem.com.tr
  • 2004 - 2008Denizli Devlet Hastanesi, Hematoloji Kliniğiacibadem.com.tr
  • 1998 - 2000Marmara Üniversitesi Tıp Fakültesi, İç Hastalıkları ABD, Hematoloji BD / Araştırma Görevlisiacibadem.com.tr
  • 1994 - 1998Marmara Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı / Araştırma Görevlisiacibadem.com.tr
  • 1992 - 1994Dicle Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı / Araştırma Görevlisiacibadem.com.tr

Education

  • 2013Yeditepe Üniversitesi Tıp Fakültesi, İç Hastalıkları ABD, Hematoloji BD / Profesör Doktor, Digeracibadem.com.tr
  • 2004KTÜ Tıp Fakültesi, İç Hastalıkları ABD, Hematoloji BD / Öğretim Üyesi Doçent Doktor, Digeracibadem.com.tr
  • 2004KTÜ Tıp Fakültesi, İç Hastalıkları ABD, Hematoloji BD, Öğretim Üyesi / Öğretim Üyesi Yardımcı Doçent Doktor, Digeracibadem.com.tr
  • 2000Marmara Üniversitesi Tıp Fakültesi, Hematoloji, Üst Uzmanlıkacibadem.com.tr
  • 1998Marmara Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 1992Marmara Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologyacibadem.com.trFrom source
  • Department name at the sourceKemik İliği Nakli Merkezi (Erişkin)acibadem.com.trFrom source
  • InstitutionAcıbadem Atakent Hastanesiacibadem.com.trFrom source
  • Area of workMultiple MyelomaExtracted from 3 publications · Model version —From source
  • Publications35 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 21:07https://www.acibadem.com.tr/doktor/s-sami-karti/acibadem.com.tr

Scientific work

Publications on Multiple Myeloma

35 publications

  1. A comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma

    Transfusion and Apheresis Science, 2025

    DOI 10.1016/j.transci.2025.104183 PMID 40627978 Source: OpenAlex

  2. C-reactive Protein Guided Empirical Antibiotic Therapy Versus Standardized Neutropenic Fever Approach in Patients Undergoing High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation

    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2025

    DOI 10.4274/bmj.galenos.2025.2024.12-1 Source: OpenAlex

  3. Outcomes of Treosulfan Vs. Busulfan Based Conditioning Regimens in Adult Patients Undergoing Allogeneic HSCT: Real Life Data from a Single Center

    Blood, 2023

    DOI 10.1182/blood-2023-189049 Source: OpenAlex

  4. P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD DATA FROM TURKEY

    HemaSphere, 2022

    DOI 10.1097/01.hs9.0000847772.34235.05 Open-access full textSource: OpenAlex

  5. Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma

    Clinical Lymphoma Myeloma & Leukemia, 2020

    DOI 10.1016/j.clml.2020.02.017 PMID 32482539 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. PS1556 BRUTON TYROSINE KINASE INHIBITOR IS AN EFFECTIVE STEROID‐SPARING AGENT IN CHRONIC GRAFT‐VERSUS‐HOST DISEASE

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000564480.84127.74 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  7. SYSTEMIC IMMUNE RESPONSE BEFORE AND AFTER TREATMENT OF HELICOBACTER PYLORI INFECTION

    Yeditepe Medical Journal, 2013

    DOI 10.15659/yeditepemj.15.10.155 Source: OpenAlex

  8. Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients

    Endocrine, 2009

    DOI 10.1007/s12020-009-9157-3 PMID 19259830 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients

    International Journal of Clinical Practice, 2006

    DOI 10.1111/j.1368-5031.2006.00786.x PMID 16620355 56 citations (Europe PMC) Source: OpenAlex

  10. Evaluation of human albumin infusion indications in our hospital Hastanemizde human albumin infüzyon endikasyonlarinin deǧerlendirilmesi

    2006

    Source: OpenAlex

View all 35 publications